Selected research
Market Structure
Global GMP Cell Banking Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global GMP Cell Banking market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for GMP Cell Banking is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for GMP Cell Banking is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for GMP Cell Banking is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for GMP Cell Banking is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of GMP Cell Banking include Thermo Fisher, Merck KGaA, Lonza, Wuxi Apptec, Texcell, SGS Life Sciences, Sartorius, ProBi and Precision for Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global GMP Cell Banking market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of GMP Cell Banking and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents GMP Cell Banking revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the GMP Cell Banking market size, projected growth trends, production technologies, key applications, and end-use industries.
GMP Cell Banking Segment by Company
Thermo Fisher
Merck KGaA
Lonza
Wuxi Apptec
Texcell
SGS Life Sciences
Sartorius
ProBi
Precision for Medicine
Kryosphere
Goodwin Biotechnology
Eurofins Scientific
Charles River
Catalent
GMP Cell Banking Segment by Type
Mammalian Cell
Insect Cell
Microbial Cell
Others
GMP Cell Banking Segment by Application
Biopharmaceutical Companies
Contract Manufacturing Organizations
GMP Cell Banking Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Cell Banking market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP Cell Banking and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Cell Banking.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of GMP Cell Banking in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GMP Cell Banking industry.
Chapter 3: Detailed analysis of GMP Cell Banking companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GMP Cell Bankingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mammalian Cell
- Insect Cell
- Microbial Cell
- Others
Applications
- Biopharmaceutical Companies
- Contract Manufacturing Organizations
Companies covered
- Thermo Fisher
- Merck KGaA
- Lonza
- Wuxi Apptec
- Texcell
- SGS Life Sciences
- Sartorius
- ProBi
- Precision for Medicine
- Kryosphere
- Goodwin Biotechnology
- Eurofins Scientific
- Charles River
- Catalent
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global GMP Cell Banking Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Mammalian Cell
- 1.2.3 Insect Cell
- 1.2.4 Microbial Cell
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global GMP Cell Banking Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Biopharmaceutical Companies
- 1.3.3 Contract Manufacturing Organizations
- 1.4 Global Market Growth Prospects
- 1.5 Global GMP Cell Banking Growth Trends by Region
- 1.5.1 Global GMP Cell Banking Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 GMP Cell Banking Market Size by Region (2021-2026)
- 1.5.3 GMP Cell Banking Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global GMP Cell Banking Market Dynamics
- 2.1 GMP Cell Banking Industry Trends
- 2.2 GMP Cell Banking Industry Drivers
- 2.3 GMP Cell Banking Industry Opportunities and Challenges
- 2.4 GMP Cell Banking Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global GMP Cell Banking Revenue by Company (2021-2026)
- 3.2 Global GMP Cell Banking Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global GMP Cell Banking Key Company Head office and Area Served
- 3.4 Global GMP Cell Banking Company, Product Type & Application
- 3.5 Global GMP Cell Banking Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global GMP Cell Banking Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 GMP Cell Banking Players Market Share by Revenue in 2025
- 3.6.3 2025 GMP Cell Banking Tier 1, Tier 2, and Tier 3
4 GMP Cell Banking Market by Type
- 4.1 Global GMP Cell Banking Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global GMP Cell Banking Market Size by Type (2021-2032)
- 4.3 Global GMP Cell Banking Market Size Share by Type (2021-2032)
5 GMP Cell Banking Market by Application
- 5.1 Global GMP Cell Banking Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global GMP Cell Banking Market Size by Application (2021-2032)
- 5.3 Global GMP Cell Banking Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Thermo Fisher
- 6.1.1 Thermo Fisher Company Information
- 6.1.2 Thermo Fisher Business Overview
- 6.1.3 Thermo Fisher GMP Cell Banking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Thermo Fisher GMP Cell Banking Product Portfolio
- 6.1.5 Thermo Fisher Recent Developments
- 6.2 Merck KGaA
- 6.2.1 Merck KGaA Company Information
- 6.2.2 Merck KGaA Business Overview
- 6.2.3 Merck KGaA GMP Cell Banking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Merck KGaA GMP Cell Banking Product Portfolio
- 6.2.5 Merck KGaA Recent Developments
- 6.3 Lonza
- 6.3.1 Lonza Company Information
- 6.3.2 Lonza Business Overview
- 6.3.3 Lonza GMP Cell Banking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Lonza GMP Cell Banking Product Portfolio
- 6.3.5 Lonza Recent Developments
- 6.4 Wuxi Apptec
- 6.4.1 Wuxi Apptec Company Information
- 6.4.2 Wuxi Apptec Business Overview
- 6.4.3 Wuxi Apptec GMP Cell Banking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Wuxi Apptec GMP Cell Banking Product Portfolio
- 6.4.5 Wuxi Apptec Recent Developments
- 6.5 Texcell
- 6.5.1 Texcell Company Information
- 6.5.2 Texcell Business Overview
- 6.5.3 Texcell GMP Cell Banking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Texcell GMP Cell Banking Product Portfolio
- 6.5.5 Texcell Recent Developments
- 6.6 SGS Life Sciences
- 6.6.1 SGS Life Sciences Company Information
- 6.6.2 SGS Life Sciences Business Overview
- 6.6.3 SGS Life Sciences GMP Cell Banking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 SGS Life Sciences GMP Cell Banking Product Portfolio
- 6.6.5 SGS Life Sciences Recent Developments
- 6.7 Sartorius
- 6.7.1 Sartorius Company Information
- 6.7.2 Sartorius Business Overview
- 6.7.3 Sartorius GMP Cell Banking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Sartorius GMP Cell Banking Product Portfolio
- 6.7.5 Sartorius Recent Developments
- 6.8 ProBi
- 6.8.1 ProBi Company Information
- 6.8.2 ProBi Business Overview
- 6.8.3 ProBi GMP Cell Banking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 ProBi GMP Cell Banking Product Portfolio
- 6.8.5 ProBi Recent Developments
- 6.9 Precision for Medicine
- 6.9.1 Precision for Medicine Company Information
- 6.9.2 Precision for Medicine Business Overview
- 6.9.3 Precision for Medicine GMP Cell Banking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Precision for Medicine GMP Cell Banking Product Portfolio
- 6.9.5 Precision for Medicine Recent Developments
- 6.10 Kryosphere
- 6.10.1 Kryosphere Company Information
- 6.10.2 Kryosphere Business Overview
- 6.10.3 Kryosphere GMP Cell Banking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Kryosphere GMP Cell Banking Product Portfolio
- 6.10.5 Kryosphere Recent Developments
- 6.11 Goodwin Biotechnology
- 6.11.1 Goodwin Biotechnology Company Information
- 6.11.2 Goodwin Biotechnology Business Overview
- 6.11.3 Goodwin Biotechnology GMP Cell Banking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Goodwin Biotechnology GMP Cell Banking Product Portfolio
- 6.11.5 Goodwin Biotechnology Recent Developments
- 6.12 Eurofins Scientific
- 6.12.1 Eurofins Scientific Company Information
- 6.12.2 Eurofins Scientific Business Overview
- 6.12.3 Eurofins Scientific GMP Cell Banking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Eurofins Scientific GMP Cell Banking Product Portfolio
- 6.12.5 Eurofins Scientific Recent Developments
- 6.13 Charles River
- 6.13.1 Charles River Company Information
- 6.13.2 Charles River Business Overview
- 6.13.3 Charles River GMP Cell Banking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Charles River GMP Cell Banking Product Portfolio
- 6.13.5 Charles River Recent Developments
- 6.14 Catalent
- 6.14.1 Catalent Company Information
- 6.14.2 Catalent Business Overview
- 6.14.3 Catalent GMP Cell Banking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Catalent GMP Cell Banking Product Portfolio
- 6.14.5 Catalent Recent Developments
7 North America
- 7.1 North America GMP Cell Banking Market Size (2021-2032)
- 7.2 North America GMP Cell Banking Market Size by Type
- 7.2.1 North America GMP Cell Banking Market Size by Type (2021-2026)
- 7.2.2 North America GMP Cell Banking Market Size by Type (2027-2032)
- 7.2.3 North America GMP Cell Banking Market Share by Type (2021-2032)
- 7.3 North America GMP Cell Banking Market Size by Application
- 7.3.1 North America GMP Cell Banking Market Size by Application (2021-2026)
- 7.3.2 North America GMP Cell Banking Market Size by Application (2027-2032)
- 7.3.3 North America GMP Cell Banking Market Share by Application (2021-2032)
- 7.4 North America GMP Cell Banking Market Size by Country
- 7.4.1 North America GMP Cell Banking Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America GMP Cell Banking Market Size by Country (2021-2026)
- 7.4.3 North America GMP Cell Banking Market Size by Country (2027-2032)
- 7.4.4 North America GMP Cell Banking Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe GMP Cell Banking Market Size (2021-2032)
- 8.2 Europe GMP Cell Banking Market Size by Type
- 8.2.1 Europe GMP Cell Banking Market Size by Type (2021-2026)
- 8.2.2 Europe GMP Cell Banking Market Size by Type (2027-2032)
- 8.2.3 Europe GMP Cell Banking Market Share by Type (2021-2032)
- 8.3 Europe GMP Cell Banking Market Size by Application
- 8.3.1 Europe GMP Cell Banking Market Size by Application (2021-2026)
- 8.3.2 Europe GMP Cell Banking Market Size by Application (2027-2032)
- 8.3.3 Europe GMP Cell Banking Market Share by Application (2021-2032)
- 8.4 Europe GMP Cell Banking Market Size by Country
- 8.4.1 Europe GMP Cell Banking Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe GMP Cell Banking Market Size by Country (2021-2026)
- 8.4.3 Europe GMP Cell Banking Market Size by Country (2027-2032)
- 8.4.4 Europe GMP Cell Banking Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China GMP Cell Banking Market Size (2021-2032)
- 9.2 China GMP Cell Banking Market Size by Type
- 9.2.1 China GMP Cell Banking Market Size by Type (2021-2026)
- 9.2.2 China GMP Cell Banking Market Size by Type (2027-2032)
- 9.2.3 China GMP Cell Banking Market Share by Type (2021-2032)
- 9.3 China GMP Cell Banking Market Size by Application
- 9.3.1 China GMP Cell Banking Market Size by Application (2021-2026)
- 9.3.2 China GMP Cell Banking Market Size by Application (2027-2032)
- 9.3.3 China GMP Cell Banking Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia GMP Cell Banking Market Size (2021-2032)
- 10.2 Asia GMP Cell Banking Market Size by Type
- 10.2.1 Asia GMP Cell Banking Market Size by Type (2021-2026)
- 10.2.2 Asia GMP Cell Banking Market Size by Type (2027-2032)
- 10.2.3 Asia GMP Cell Banking Market Share by Type (2021-2032)
- 10.3 Asia GMP Cell Banking Market Size by Application
- 10.3.1 Asia GMP Cell Banking Market Size by Application (2021-2026)
- 10.3.2 Asia GMP Cell Banking Market Size by Application (2027-2032)
- 10.3.3 Asia GMP Cell Banking Market Share by Application (2021-2032)
- 10.4 Asia GMP Cell Banking Market Size by Country
- 10.4.1 Asia GMP Cell Banking Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia GMP Cell Banking Market Size by Country (2021-2026)
- 10.4.3 Asia GMP Cell Banking Market Size by Country (2027-2032)
- 10.4.4 Asia GMP Cell Banking Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa GMP Cell Banking Market Size (2021-2032)
- 11.2 South America, Middle East & Africa GMP Cell Banking Market Size by Type
- 11.2.1 South America, Middle East & Africa GMP Cell Banking Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa GMP Cell Banking Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa GMP Cell Banking Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa GMP Cell Banking Market Size by Application
- 11.3.1 South America, Middle East & Africa GMP Cell Banking Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa GMP Cell Banking Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa GMP Cell Banking Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa GMP Cell Banking Market Size by Country
- 11.4.1 South America, Middle East & Africa GMP Cell Banking Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa GMP Cell Banking Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa GMP Cell Banking Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa GMP Cell Banking Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst